Bioprocessing - Upstream & Downstream

Where would the biopharma industry be without Protein A? And can it ever be topped?

A look a Millipore Sigma’s global network of collaboration facilities, ‘M-Lab’

Nine years ago we set out to characterize and evaluate our raw materials - this is what we found out…

Scaling up a bioprocess doesn’t need to be a headache - especially when there are firms out there that can lend a helping hand

New analytical techniques could be used alongside old ones to get the best of both worlds

Sitting down with Steve Oh from the Stem Cell Bioprocessing, Bioprocessing Technology Institute, A*STAR

When it comes to cryopreserving cell therapies, there's a right way - and a wrong way…

Five gurus discuss the exciting developments in advanced medicine, and what the field needs to move forward.

Tracing the supply chain back to raw materials and learning how fundamental research is driving advances in cell culture media.

Patheon's Steve Lam shares his lessons learned over three decades in bioprocessing.